Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

AIM ImmunoTech Q2 EPS $(3.68) Beats $(8.00) Estimate, Sales $25.00K Miss $100.00K Estimate

Author: Benzinga Newsdesk | August 15, 2025 08:11am
AIM ImmunoTech (AMEX:AIM) reported quarterly losses of $(3.68) per share which beat the analyst consensus estimate of $(8.00) by 54 percent. This is a 12166.67 percent decrease over losses of $(0.03) per share from the same period last year. The company reported quarterly sales of $25.00 thousand which missed the analyst consensus estimate of $100.00 thousand by 75.00 percent. This is a 50.00 percent decrease over sales of $50.00 thousand the same period last year.

Posted In: AIM


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist